Quarterly Metrics: Quick and Current Ratios for Liquidia Corp (LQDA)

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

As of close of business last night, Liquidia Corp’s stock clocked out at $19.48, up 10.18% from its previous closing price of $17.68. In other words, the price has increased by $10.18 from its previous closing price. On the day, 2.82 million shares were traded. LQDA stock price reached its highest trading level at $19.955 during the session, while it also had its lowest trading level at $17.82.

Ratios:

To gain a deeper understanding of LQDA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.91 and its Current Ratio is at 2.93. In the meantime, Its Debt-to-Equity ratio is 2.21 whereas as Long-Term Debt/Eq ratio is at 2.21.

On December 20, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 28 ’25 when Adair Jason sold 454 shares for $19.54 per share. The transaction valued at 8,871 led to the insider holds 193,180 shares of the business.

Boyle Dana sold 1,063 shares of LQDA for $20,771 on Jul 28 ’25. The Chief Accounting Officer now owns 186,105 shares after completing the transaction at $19.54 per share. On Jul 21 ’25, another insider, Saggar Rajeev, who serves as the Chief Medical Officer of the company, sold 2,526 shares for $14.54 each. As a result, the insider received 36,728 and left with 268,887 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LQDA now has a Market Capitalization of 1665237888 and an Enterprise Value of 1643145600. For the stock, the TTM Price-to-Sale (P/S) ratio is 117.77 while its Price-to-Book (P/B) ratio in mrq is 33.42. Its current Enterprise Value per Revenue stands at 116.173 whereas that against EBITDA is -13.004.

Stock Price History:

The Beta on a monthly basis for LQDA is 0.22, which has changed by 0.761302 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, LQDA has reached a high of $20.33, while it has fallen to a 52-week low of $8.26. The 50-Day Moving Average of the stock is 27.43%, while the 200-Day Moving Average is calculated to be 41.00%.

Shares Statistics:

It appears that LQDA traded 2.47M shares on average per day over the past three months and 3129390 shares per day over the past ten days. A total of 85.30M shares are outstanding, with a floating share count of 69.13M. Insiders hold about 19.13% of the company’s shares, while institutions hold 64.32% stake in the company. Shares short for LQDA as of 1752537600 were 22399615 with a Short Ratio of 9.07, compared to 1749772800 on 19503882. Therefore, it implies a Short% of Shares Outstanding of 22399615 and a Short% of Float of 32.630002000000005.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.